These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23857060)

  • 1. TMPRSS4 as a poor prognostic factor for triple-negative breast cancer.
    Cheng D; Kong H; Li Y
    Int J Mol Sci; 2013 Jul; 14(7):14659-68. PubMed ID: 23857060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
    Albergaria A; Ricardo S; Milanezi F; Carneiro V; Amendoeira I; Vieira D; Cameselle-Teijeiro J; Schmitt F
    BMC Cancer; 2011 Jul; 11():299. PubMed ID: 21762477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.
    Zhao H; Yang M; Zhao J; Wang J; Zhang Y; Zhang Q
    Med Oncol; 2013 Mar; 30(1):475. PubMed ID: 23371253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.
    Wu M; Wei W; Xiao X; Guo J; Xie X; Li L; Kong Y; Lv N; Jia W; Zhang Y; Xie X
    Med Oncol; 2012 Dec; 29(5):3240-9. PubMed ID: 22661383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic features and prognosis of triple negative breast cancer].
    Zhou T; Yang L; Ma GM; Li CX; Bai Y; Zhao JA; Wang XL; Geng CZ
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2261-4. PubMed ID: 20095338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of TMPRSS4 expression in patients with breast cancer.
    Liang B; Wu M; Bu Y; Zhao A; Xie F
    Med Oncol; 2013 Jun; 30(2):497. PubMed ID: 23420063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features of triple-negative breast cancer in Taiwanese women.
    Yao-Lung K; Dar-Ren C; Tsai-Wang C
    Int J Clin Oncol; 2011 Oct; 16(5):500-5. PubMed ID: 21455625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High TMPRSS4 expression is a predictor of poor prognosis in cervical squamous cell carcinoma.
    Cheng D; Liang B; Li Y
    Cancer Epidemiol; 2013 Dec; 37(6):993-7. PubMed ID: 24012692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients.
    Bae SY; La Choi Y; Kim S; Kim M; Kim J; Jung SP; Choi MY; Lee SK; Kil WH; Lee JE; Nam SJ
    Breast Cancer Res Treat; 2013 Jun; 139(3):741-50. PubMed ID: 23722313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].
    Ma JG; Wang NJ; Yu WJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1729-32. PubMed ID: 22027778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
    Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
    Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple negative breast carcinoma is a prognostic factor in Taiwanese women.
    Lin C; Chien SY; Chen LS; Kuo SJ; Chang TW; Chen DR
    BMC Cancer; 2009 Jun; 9():192. PubMed ID: 19534825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased HCRP1 expression is associated with poor prognosis in breast cancer patients.
    Xu J; Yang W; Wang Q; Zhang Q; Li X; Lin X; Liu X; Qin Y
    Int J Clin Exp Pathol; 2014; 7(11):7915-22. PubMed ID: 25550832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas.
    Karihtala P; Kauppila S; Soini Y; Arja-Jukkola-Vuorinen
    BMC Cancer; 2011 Jun; 11():262. PubMed ID: 21693047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer.
    Zhao Y; Yang N; Wang X; Huang Y; Zhou X; Zhang D
    Clin Transl Oncol; 2020 Dec; 22(12):2275-2285. PubMed ID: 32447641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
    Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
    Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.
    Tang D; Xu S; Zhang Q; Zhao W
    Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of tyrosine-protein phosphatase nonreceptor type 12 is associated with lymph node metastasis and poor prognosis in operable triple-negative breast cancer.
    Wu MQ; Hu P; Gao J; Wei WD; Xiao XS; Tang HL; Li X; Ge QD; Jia WH; Liu RB; Xie XM
    Asian Pac J Cancer Prev; 2013; 14(1):287-92. PubMed ID: 23534739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer.
    Li Y; Cao J; Zhou Y; Mao F; Shen S; Sun Q
    Sci Rep; 2019 Jul; 9(1):10544. PubMed ID: 31332233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.